Birch triterpenes is under clinical development by Chiesi Farmaceutici and currently in Phase II for Radiodermatitis.
To achieve our goals, we mainly use Populus trichocarpa and Betula pendula as model species. Yrjö 'Ykä' is a Principal Investigator/Group Leader at BI and Professor of Plant Developmental Biology at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results